Stockscreener 앱 받기
0.61
31.01%
0.1444
전일 마감가:
$0.4656
열려 있는:
$0.4853
하루 거래량:
3.26M
Relative Volume:
12.73
시가총액:
$2.58M
수익:
$502.40K
순이익/손실:
$-7.91M
주가수익비율:
-0.0612
EPS:
-9.972
순현금흐름:
$-4.32M
1주 성능:
+15.88%
1개월 성능:
-26.50%
6개월 성능:
-62.80%
1년 성능:
-85.22%
1일 변동 폭
$0.47
$0.6771
1주일 범위
$0.34
$0.6771
52주 변동 폭
$0.34
$6.00
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
SXTP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
0.61 | 1.97M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
Short Interest in 60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Rises By 81.6% - Defense World
Bear Alert: What is LLYVKs 5 year growth outlookJuly 2025 Short Interest & Reliable Trade Execution Plans - baoquankhu1.vn
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Shares to Reverse Split on Tuesday, January 20th - Defense World
60 Degrees Pharmaceuticals to implement 1:4 reverse stock split By Investing.com - Investing.com Nigeria
60 Degrees Pharmaceuticals (SXTP) to Implement 1-for-4 Reverse Stock Split Effective January 20, 2026 - Intellectia AI
60 Degrees Pharmaceuticals to implement 1:4 reverse stock split - Investing.com
60 Degrees Pharmaceuticals, Inc. announces approval of reverse stock split ratio - marketscreener.com
60 Degree Pharmaceuticals Announces One-for-Four Reverse Stock Split Effective January 20, 2026 - Quiver Quantitative
Nasdaq-listed 60 Degrees Pharma shrinks shares 4-for-1 on Jan. 20 reverse - Stock Titan
Rate Hike: Is TriSalus Life Sciences Inc stock a value trapRecession Risk & AI Driven Stock Price Forecasts - baoquankhu1.vn
Enlivex Therapeutics and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - fdlreporter.com
Here's why 60 Degrees Pharmaceuticals Inc. (SXTP) looks ripe for bottom fishing - MSN
Aug Action: Will 60 Degrees Pharmaceuticals Inc Equity Warrant benefit from geopolitical trendsMarket Trend Report & Intraday High Probability Alerts - baoquankhu1.vn
Hedge Fund Bets: Why retail investors pile into 60 Degrees Pharmaceuticals Inc Equity Warrant stockJuly 2025 Pullbacks & Verified Entry Point Signals - Bộ Nội Vụ
Recap Report: Is 60 Degrees Pharmaceuticals Inc Equity Warrant stock a top pick in earnings seasonWeekly Investment Summary & Capital Protection Trading Alerts - Bộ Nội Vụ
Winners Losers: Is 60 Degrees Pharmaceuticals Inc. stock a defensive play in 2025Portfolio Performance Report & Safe Entry Trade Reports - Bộ Nội Vụ
Why 60 Degrees Pharmaceuticals Inc. stock attracts global investorsJuly 2025 Catalysts & Free Low Drawdown Momentum Trade Ideas - Улправда
Analyst Calls: Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoptionEarnings Overview Report & High Yield Equity Trading Tips - Улправда
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock benefit from AI adoptionEarnings Beat & AI Forecasted Stock Moves - Улправда
Shorts Report: Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoption2025 Earnings Surprises & Real-Time Stock Price Movement Reports - ulpravda.ru
What risks investors should watch in 60 Degrees Pharmaceuticals Inc. stockPortfolio Return Report & Fast Entry High Yield Stock Tips - Улправда
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryDividend Hike & Verified Entry Point Detection - Улправда
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to analysts2025 Valuation Update & Weekly High Potential Stock Alerts - Улправда
Movement Recap: Is 60 Degrees Pharmaceuticals Inc. stock vulnerable to regulatory risksJuly 2025 Intraday Action & Weekly Setup with ROI Potential - Улправда
Is 60 Degrees Pharmaceuticals Inc. stock a top pick in earnings seasonEarnings Recap Summary & Verified Technical Signals - Улправда
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexMarket Activity Recap & Weekly Return Optimization Plans - Улправда
Published on: 2026-01-09 01:34:54 - Улправда
Will 60 Degrees Pharmaceuticals Inc. stock benefit from AI adoptionEarnings Overview Report & High Yield Equity Trading Tips - Улправда
Is 60 Degrees Pharmaceuticals Inc. stock a top momentum playJuly 2025 Analyst Calls & Long Hold Capital Preservation Plans - Улправда
Published on: 2026-01-08 21:47:54 - Улправда
Will 60 Degrees Pharmaceuticals Inc. Equity Warrant stock deliver long term returnsJuly 2025 Short Interest & Safe Capital Growth Tips - Улправда
Published on: 2026-01-08 20:08:34 - Улправда
Will 60 Degrees Pharmaceuticals Inc. stock deliver consistent dividendsWeekly Trade Report & Long Hold Capital Preservation Tips - Улправда
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index
60 Degrees Pharma outlines growth strategy in investor webinar - TipRanks
60 Degrees Pharmaceuticals, Inc. Updates on Clinical Development and Regulatory Strategy - TradingView — Track All Markets
Why 60 Degrees Pharmaceuticals Inc. Equity Warrant stock appeals to dividend seekers2026 world cup usa national team final star players transition play group prediction tactical review - Улправда
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Sees Large Growth in Short Interest - Defense World
60 Degrees Pharmaceuticals, Inc. Confirms Continuation of B-FREE Study to Assess ARAKODA® for Chronic Babesiosis Treatment - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Detection of Babesia - GlobeNewswire
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State - Sahm
60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Coloradoan
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
60 Degrees Pharmaceuticals Inc 주식 (SXTP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
| XU CHERYL | Director |
Jun 03 '25 |
Buy |
2.88 |
5,000 |
14,410 |
15,816 |
4.73%
0.92%
자본화:
|
볼륨(24시간):